54788-38-4

Basic information

• Product Name: 2-Chloro-4-methoxy-1-methylbenzene
• Synonyms: BENZENE, 2-CHLORO-4-METHOXY-1-METHYL;2-Chloro-4-Methoxytoluene;2-CHLORO-4-METHOXY-1-METHYLBENZENE;3-CHLORO-4-METHYLANISOLE;2-Chloro-4-Methoxy-1-MethylBenzene97%;3-CHLORO-4-METHYLANISOLE / 2-CHLORO-4-METHOXYTOLUENE
• CAS NO: 54788-38-4
• Molecular Formula: C₈H₉ClO
• Molecular Weight: 156.61
• Product Categories: Anisole;Anisoles, Alkyloxy Compounds & Phenylacetates;Chlorine Compounds
• Mol File: 54788-38-4.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 76°C/2mm
• Flash Point: 76°C/2mm
• Appearance: /
• Density: 1.105g/cm³
• Vapor Pressure: 0.29mmHg at 25°C
• Refractive Index: 1.5340
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-Chloro-4-methoxy-1-methylbenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-4-methoxy-1-methylbenzene(54788-38-4)
• EPA Substance Registry System: 2-Chloro-4-methoxy-1-methylbenzene(54788-38-4)

Safety Data

• Hazard Codes: Xi,F
• HazardClass: IRRITANT, FLAMMABLE
• Hazardous Substances Data: 54788-38-4(Hazardous Substances Data)

Usage

Chemical Properties

Colorless liquid

InChI:InChI=1/C8H9ClO/c1-6-3-4-7(10-2)5-8(6)9/h3-5H,1-2H3

Upstream product

• 13061-96-6 dihydroxy-methyl-borane 
• 50638-46-5 4-bromo-3-chloroanisole 
• 615-62-3 3-chloro-4-methylphenol 
• 74-88-4 methyl iodide 
• 42194-65-0 4-methoxybenzyl Co(III)(dmgH)2py 
• 95-74-9 3-chloro-p-toluidine 
• 56180-49-5 4-chloro-4-methylcyclohexa-2,5-dien-1-one 
• 104-93-8 p-methylanizole 
• 77-78-1 dimethyl sulfate 
• 7782-50-5 chlorine 

Downstream Products

• 54788-17-9 2-chloro-4-methoxybenzyl bromide 
• 108103-66-8 N-butyl-5-methoxy-2-methylaniline 
• 156267-11-7 5-methoxy-2-methyl-N-methylaniline 
• 50868-72-9 5-methoxy-o-toluidine 
• 108103-70-4 5-methoxy-2-methyl-N-octylaniline 
• 22246-19-1 5-methoxy-2-methylbenzonitrile 
• 566945-69-5 ethyl [4-(3-bromophenyl)-7-chloro-6-methyl-2-oxo-2H-chromen-3-yl]acetate 
• 1226452-12-5 [3-[7-chloro-3-[2-[[4-fluoro-2-(trifluoromethyl)phenyl]amino]-2-oxoethyl]-6-methyl-2-oxo-2H-chromen-4-yl]phenyl]acetic acid 
• 566944-74-9 methyl [3-[7-chloro-3-[2-[[4-fluoro-2-(trifluoromethyl)phenyl]amino]-2-oxoethyl]-6-methyl-2-oxo-2H-chromen-4-yl]phenyl]acetate 
• 566944-99-8 (2E,4E)-5-{3-[7-chloro-3-(2-{[4-fluoro-2-(trifluoromethyl)phenyl]amino}-2-oxoethyl)-6-methyl-2-oxo-2H-chromen-4-yl]phenyl}-2,4-pentadienoic acid 
• 566945-08-2 (2E)-3-{3-[7-chloro-3-(2-{[4-fluoro-2-(trifluoromethyl)phenyl]amino}-2-oxoethyl)-6-methyl-2-oxo-2H-chromen-4-yl]phenyl}-2-methylacrylic acid 
• 566945-07-1 (2E)-3-{3-[7-chloro-3-(2-{[4-fluoro-2-(trifluoromethyl)phenyl]amino}-2-oxoethyl)-6-methyl-2-oxo-2H-chromen-4-yl]phenyl}-2-butenoic acid 
• 434333-03-6 (2E)-3-[3-[7-chloro-3-[2-[[4-fluoro-2-(trifluoromethyl)phenyl]amino]-2-oxoethyl]-6-methyl-2-oxo-2H-chromen-4-yl]phenyl]acrylic acid 

Relevant articles and documents

Bicyclic sulfonamide compounds as sodium channel inhibitors

The present invention provides compounds of Formula I, and pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav1.7. The compounds are useful for the treatment of diseases associated with the activity of sodium channels such as pain disorders and itch. Also provided are pharmaceutical compositions containing compounds of the present invention.

PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE

The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea

Process for the manufacture of fluoran compounds

A process for the preparation of a fluoran compound of the formula STR1 wherein R, R1, R2 and R4 are each independently hydrogen, halogen, lower alkyl or lower alkoxy, R3 is hydrogen, halogen, lower alkyl, lower alkoxy or --NX3 X4, or (R1 and R2) or (R3 and R4) each pair together with the carbon atoms to which they are attached, form a fused benzene nucleus, X1, X2, X3 and X4 are each independently hydrogen, alkyl containing not more than 12 carbon atoms which is unsubstituted or substituted by cyano, halogen, hydroxy, tetrahydrofuryl or lower alkoxy, or are cycloalkyl, aryl or aralkyl or (X1 and X2) or (X3 and X4) are each independently together with the nitrogen to which are attached a 5- or 6-membered heterocyclic ring, and the ring A is unsubstituted or substituted by halogen, nitro, lower alkyl, lower alkylthio, lower alkoxy, lower alkoxycarbonyl, amino, mono-lower alkylamino, di-lower alkylamino or lower alkyl carbonylamino, which process comprises (1) reacting a ketonic acid of the formula STR2 with a substituted phenol derivative of the formula STR3 wherein Z is hydrogen, lower alkyl, formyl or lower alkanoyl and A, R, R1, R2, R3, R4, X1 and X2 have the given meanings, (2) adding the reaction product to an aqueous-organic liquor containing a non-polar organic solvent and a base at a temperature of 50° to 90° C., (3) separating the organic phase and (4) removing the organic solvent to obtain the fluoran of the formula (1).